Calcineurin activation causes retinal ganglion cell degeneration.

dc.contributor.author

Qu, Juan

dc.contributor.author

Matsouaka, Roland

dc.contributor.author

Betensky, Rebecca A

dc.contributor.author

Hyman, Bradley T

dc.contributor.author

Grosskreutz, Cynthia L

dc.coverage.spatial

United States

dc.date.accessioned

2017-11-01T16:32:28Z

dc.date.available

2017-11-01T16:32:28Z

dc.date.issued

2012

dc.description.abstract

PURPOSE: We previously reported that calcineurin, a Ca(2+)/calmodulin-dependent serine/threonine phosphatase, is activated and proposed that it participates in retinal ganglion cell (RGC) apoptosis in two rodent ocular hypertension models. In this study, we tested whether calcineurin activation by itself, even in the absence of ocular hypertension, is sufficient to cause RGC degeneration. METHODS: We compared RGC and optic nerve morphology after adeno-associated virus serotype 2 (AAV2)-mediated transduction of RGCs with constitutively active calcineurin (CaNCA) or unactivated, wild-type calcineurin (CaNwt). Retinas and optic nerves were harvested 7-16 weeks after injection of the AAV into mouse vitreous. In flatmounted retinas, the transduced RGCs were identified with immunohistochemistry. The morphology of the RGCs was revealed by immunostaining for neurofilament SMI32 or by using GFP-M transgenic mice. A modified Sholl analysis was applied to analyze the RGC dendritic morphology. Optic nerve damage was assessed with optic nerve grading according to the Morrison standard. RESULTS: CaNwt and CaNCA were highly expressed in the injected eyes. Compared to the CaNwt-expressing RGCs, the CaNCA-expressing RGCs had smaller somas, smaller dendritic field areas, shorter total dendrite lengths, and simpler dendritic branching patterns. At 16 weeks, the CaNCA-expressing eyes had greater optic nerve damage than the CaNwt-expressing eyes. CONCLUSIONS: Calcineurin activation is sufficient to cause RGC dendritic degeneration and optic nerve damage. These data support the hypothesis that calcineurin activation is an important mediator of RGC degeneration, and are consistent with the hypothesis that calcineurin activation may contribute to RGC neurodegeneration in glaucoma.

dc.identifier

https://www.ncbi.nlm.nih.gov/pubmed/23233785

dc.identifier.eissn

1090-0535

dc.identifier.uri

https://hdl.handle.net/10161/15726

dc.language

eng

dc.publisher

MOLECULAR VISION

dc.relation.ispartof

Mol Vis

dc.subject

Animals

dc.subject

Axons

dc.subject

Calcineurin

dc.subject

Dendrites

dc.subject

Dependovirus

dc.subject

Enzyme Activation

dc.subject

Genetic Vectors

dc.subject

Green Fluorescent Proteins

dc.subject

Immunohistochemistry

dc.subject

Intravitreal Injections

dc.subject

Mice

dc.subject

Mice, Transgenic

dc.subject

Nerve Degeneration

dc.subject

Optic Nerve

dc.subject

Retinal Degeneration

dc.subject

Retinal Ganglion Cells

dc.subject

Transduction, Genetic

dc.subject

Transgenes

dc.title

Calcineurin activation causes retinal ganglion cell degeneration.

dc.type

Journal article

duke.contributor.orcid

Matsouaka, Roland|0000-0002-0271-5400

pubs.author-url

https://www.ncbi.nlm.nih.gov/pubmed/23233785

pubs.begin-page

2828

pubs.end-page

2838

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Biostatistics & Bioinformatics

pubs.organisational-group

Duke

pubs.organisational-group

Duke Clinical Research Institute

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

School of Medicine

pubs.publication-status

Published

pubs.volume

18

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Calcineurin activation causes retinal ganglion cell degeneration.pdf
Size:
5.93 MB
Format:
Adobe Portable Document Format
Description:
Published version